Gatineau medical marijuana company recalls tainted products, resumes sales
Sales of most medical marijuana products from Hydropothecary Corp. will resume after the Gatineau medical marijuana grower announced that it had recalled products affected by the discovery of trace amounts of an unapproved pesticide.
Hydropothecary announced the recall Tuesday morning, saying it was still searching for the source of the contamination at its facility in Masson-Angers, about 40 kilometres northeast of Ottawa.
The company voluntarily stopped all sales two weeks ago after a Health Canada spot check found the pesticide myclobutanil on plant samples.
Hydropothecary becomes the fourth medical marijuana producer in the past six months to recall products after testing showed the presence of myclobutanil and other pesticides not approved for use on cannabis.
Growing concerns about tainted medical marijuana prompted Health Canada earlier this month to order the country’s 43 producers to start testing for pesticides. Some companies, including Hydropothecary, had already begun such testing on their own.
